Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 17.13%20.97B | 11.67%9.84B | 5.49%17.9B | 10.61%8.81B | 18.90%16.97B | 18.59%7.97B | 41.43%14.27B | 64.76%6.72B | 66.43%10.09B | --4.08B |
| Operating income | 17.13%20.97B | 11.67%9.84B | 5.49%17.9B | 10.61%8.81B | 18.90%16.97B | 18.59%7.97B | 41.43%14.27B | 64.76%6.72B | 66.43%10.09B | 4.08B |
| Cost of sales | -15.99%-18.66B | -10.16%-8.74B | -5.64%-16.09B | -10.92%-7.93B | -18.62%-15.23B | -17.29%-7.15B | -39.87%-12.84B | -66.27%-6.1B | -68.25%-9.18B | ---3.67B |
| Operating expenses | -15.99%-18.66B | -10.16%-8.74B | -5.64%-16.09B | -10.92%-7.93B | -18.62%-15.23B | -17.29%-7.15B | -39.87%-12.84B | -66.27%-6.1B | -68.25%-9.18B | -3.67B |
| Gross profit | 27.22%2.31B | 25.27%1.1B | 4.17%1.81B | 7.90%881.72M | 21.34%1.74B | 31.31%817.18M | 57.00%1.43B | 51.32%622.33M | 50.11%913.83M | 411.27M |
| Selling expenses | -19.30%-1.74B | -16.87%-826.94M | -5.33%-1.46B | -11.43%-707.55M | -4.65%-1.39B | -1.40%-634.95M | -24.61%-1.33B | -36.60%-626.15M | -46.45%-1.06B | ---458.38M |
| Administrative expenses | -14.27%-404.51M | -12.02%-190.06M | -6.43%-353.99M | -15.80%-169.67M | -15.97%-332.6M | -12.64%-146.51M | -38.54%-286.79M | -33.78%-130.08M | -32.51%-207.01M | ---97.23M |
| Research and development expenses | -1.56%-95.66M | -6.32%-48.57M | -0.63%-94.2M | -14.37%-45.68M | -18.26%-93.6M | -11.33%-39.94M | -39.81%-79.15M | -44.38%-35.87M | -128.97%-56.61M | ---24.85M |
| Revaluation surplus | ---- | ---- | ---- | ---- | -144.09%-3.17B | -512.83%-3.17B | -909.74%-1.3B | -136.07%-517.58M | 56.28%-128.7M | ---219.25M |
| -Changes in the fair value of other assets | ---- | ---- | ---- | ---- | -144.09%-3.17B | -512.83%-3.17B | -909.74%-1.3B | -136.07%-517.58M | 56.28%-128.7M | ---219.25M |
| Impairment and provision | -231.32%-348K | -160.55%-264K | -89.57%265K | -81.92%436K | 210.43%2.54M | 223.57%2.41M | -30.02%-2.3M | 15.17%-1.95M | 43.86%-1.77M | ---2.3M |
| -Other impairment is provision | -231.32%-348K | -160.55%-264K | -89.57%265K | -81.92%436K | 210.43%2.54M | 223.57%2.41M | -30.02%-2.3M | 15.17%-1.95M | 43.86%-1.77M | ---2.3M |
| Special items of operating profit | -24.39%91.8M | -38.18%36.3M | 190.72%121.41M | 52,806.31%58.73M | -42.01%41.76M | -99.78%111K | 45.53%72.02M | 182.52%50.25M | 64.53%49.49M | --17.79M |
| Operating profit | 502.71%154.93M | 316.79%74.98M | 100.80%25.71M | 100.57%17.99M | -115.26%-3.2B | -396.61%-3.17B | -200.59%-1.49B | -71.35%-639.06M | 12.61%-494.58M | -372.95M |
| Financing cost | -5.19%-11.93M | -15.10%-6.07M | -13.02%-11.34M | -6.44%-5.27M | 1.95%-10.03M | 3.03%-4.95M | -20.45%-10.23M | -25.26%-5.11M | 17.54%-8.49M | ---4.08M |
| Share of profits of associates | ---5.96M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning before tax | 853.82%137.05M | 441.85%68.91M | 100.45%14.37M | 100.40%12.72M | -114.46%-3.21B | -393.44%-3.18B | -197.54%-1.5B | -70.85%-644.17M | 12.70%-503.07M | -377.03M |
| Tax | 1,153.44%8.94M | 699.53%5.09M | -80.68%713K | -67.75%636K | 216.37%3.69M | 1,295.15%1.97M | -318.09%-3.17M | -117.03%-165K | -68.12%1.45M | --969K |
| After-tax profit from continuing operations | 867.99%145.98M | 454.13%74M | 100.47%15.08M | 100.42%13.35M | -113.76%-3.21B | -393.01%-3.18B | -199.04%-1.5B | -71.34%-644.33M | 12.26%-501.62M | -376.06M |
| Earning after tax | 867.99%145.98M | 454.13%74M | 100.47%15.08M | 100.42%13.35M | -113.76%-3.21B | -393.01%-3.18B | -199.04%-1.5B | -71.34%-644.33M | 12.26%-501.62M | -376.06M |
| Minority profit | 53.23%-6.98M | 51.35%-4.12M | 13.66%-14.93M | -6.02%-8.47M | -52.38%-17.3M | 6.65%-7.99M | -49.76%-11.35M | -4,474.33%-8.55M | ---7.58M | ---187K |
| Profit attributable to shareholders | 409.66%152.97M | 258.01%78.12M | 100.94%30.01M | 100.69%21.82M | -114.23%-3.19B | -398.38%-3.17B | -201.33%-1.49B | -69.15%-635.78M | 13.59%-494.04M | -375.87M |
| Basic earnings per share | 376.60%0.224 | 266.67%0.11 | 100.57%0.047 | 100.13%0.03 | 30.47%-8.26 | -367.46%-23.7 | -201.52%-11.88 | 57.75%-5.07 | 13.60%-3.94 | -12 |
| Diluted earnings per share | 378.26%0.22 | 266.67%0.11 | 100.56%0.046 | 100.13%0.03 | 30.47%-8.26 | -367.46%-23.7 | -201.52%-11.88 | 57.75%-5.07 | 13.60%-3.94 | -12 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | -- | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.